Integral Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$338K Buy
933
+2
+0.2% +$685 0.07% 144
2026
Q1
$328K Sell
931
-142
-13% -$50.6K 0.08% 133
2025
Q4
$351K Buy
1,073
+147
+16% +$46.6K 0.09% 132
2025
Q3
$261K Buy
926
+3
+0.3% +$870 0.07% 140
2025
Q2
$258K Sell
923
-12
-1% -$3.4K 0.07% 137
2025
Q1
$291K Buy
+935
New +$276K 0.09% 133

Other funds holding AMGN

Integral Investment Advisors's AMGN Position: Q2 2026 in Review

Integral Investment Advisors increased its Amgen (AMGN) stake by 0.21% in Q2 2026, buying an estimated $685 and bringing the position to 933 shares worth $338K. The position accounts for 0.07% of the portfolio, ranked #144.

Integral Investment Advisors first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $351K in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Integral Investment Advisors held 933 shares of Amgen worth $338K as of Q2 2026.
  • Integral Investment Advisors bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.07% of Integral Investment Advisors's portfolio in Q2 2026, its #144 holding.
  • Integral Investment Advisors first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • Integral Investment Advisors's Amgen position peaked at $351K in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.